What You Should Know:
- Today, Sharecare announced the launch of Smart Omix, Sharecare's new scalable SaaS-based solution to empower independent researchers, clinicians, and academic institutions to conduct digitally enabled clinical research studies
- Smart Omix is made for researchers by researchers and purpose-built to address technological, economic, and talent barriers to remote observational studies more commonly encountered by
Read More
Life Sciences - Pharma | News, Analysis, Insights - HIT Consultant
Realizing the Dream of AI in Clinical Trials—How to Address Key Challenges
The clinical development process is incredibly time consuming and only yields a success rate of about 10%. One way to reduce the time, cost and success of the clinical development process is to introduce artificial intelligence (AI) into clinical trials and implement AI-driven process automation.
The dream of AI in clinical trial execution is for trial functions to run autonomously, like a self-driving car. A self-driving car knows how fast it is going, where it needs to go,
Read More
Clarify Health & Datavant Partner to Integrate Real-World Data
What You Should Know:
- Clarify Health, a cloud analytics and value-based payments platform company, and Datavant, a provider helping organizations securely connect health data expands their relationship to enable life sciences companies to connect their proprietary, first-party data in Clarify’s AI-powered Atlas analytics platform to improve clinical development and commercial operations.
- Datavant’s privacy-preserving tokenization and high-accuracy matching technologies will be used to
Read More
Upfront Acquires Patient Engagement Platform PatientBond
What You Should Know:
- Upfront acquires PatientBond, a digital patient engagement platform creating a single enterprise technology solution to drive patient acquisition and loyalty.
- The acquisition accelerates Upfront's delivery of their next-generation personalization platform. Combined with Upfront's omnichannel communications capabilities, PatientBond's robust consumer insights build and expand loyal patient-provider relationships to influence positive behavioral changes, resulting
Read More
Signal AI Acquires Healthcare Rep & Risk Insights Platform Kelp
What You Should Know:
Signal AI, the leading global External Intelligence company, today announces that it has acquired US company KELP Inc., the first actionable platform for corporate reputation. Financial details of the acquisition were not disclosed.
The healthcare industry is defined by reputation and trust. And through this acquisition Signal AI will now be able to build upon its risk management capabilities allowing healthcare companies to identify, mitigate and avoid emerging
Read More
FundamentalVR Raises $20M for VR Surgical Simulation Platform
What You Should Know:
- FundamentalVR has raised an additional $20M to significantly accelerate medical skill-transfer and increase surgical proficiency through its world-leading medical simulation platform, Fundamental Surgery.
- The funding was led by EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. The new investments follow a Series A round in October 2019 and bring the
Read More
H1 Launches AI-Powered and Evidence-Based Interactions
What You Should Know:
- H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.
- New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.
Establishing AI-Driven Efficient Workflows
H1 is
Read More
Healthcare & Life Science M&A Activity Plummets 1H’22
What You Should Know:
- The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in line with the S&P 500 decline of 16.4%.
- Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. The report reveals credit markets likely to tighten, but a healthy level of M&A is expected to continue in the growing and defensive healthcare sector.
Key Trends and
Read More
Annexus Health Raises $33M to Optimize Patient Access and Affordability
What You Should Know:
- Annexus Health, Inc. has announced its Series B financing of $33 million, which was led by leading digital health growth equity firm Transformation Capital.
- The funding is set to advance Annexus Health's mission to improve access to care and combat patient financial toxicity amid ever-rising healthcare costs
Re-Imagining the Healthcare Ecosystem by Increasing Access To Care
Annexus Health strives for a better healthcare experience for patients, more
Read More
H1 & Lokavant Partner to Power Next-Gen Clinical Trials
What You Should Know:
- H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development
- As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.
Integrating Clinical Trial Data Sources to Intelligence Platforms
Lokavant is a clinical
Read More
